Abstract:DNA methylation is a common epigenetic modification, characterized by the presence of the signature 5-methylcytosine without altering the sequence of DNA. The study of DNA methylation in mammals has gained significant attention due to its broad impact on numerous biological processes and its critical role in the onset and progression of many diseases, such as cancer and aging. Consequently, there is a pressing need for a rapid and precise method to assess methylation status. Currently, most approaches for quantifying DNA methylation rely on sodium bisulfite treatment. However, such approaches do not align with the uracil DNA glycosylase PCR system. In this study, we demonstrate the application of methylation-sensitive restriction enzymes (MSRE) and digital PCR to determine the methylation status of the Ras association domain family 1 isoform A (RASSF1A) in cancer cell lines. Digital PCR enables the precise detection and absolute quantification without the reliance on reference standards. We developed a multiplex digital PCR assay that includes the target gene RASSF1A, along with two reference genes for the purpose of monitoring digestion completion and correcting DNA input. Each sample of interest was measured both before and after a MSRE digestion. To ensure the quantification accuracy, we employed the commercially available CpGenome human methylated DNA standard with a known concentration from MilliporeSigma, treating it with and without a MSRE, and subsequently performing digital PCR experiments using Roche Digital LightCycler® IVD system with a Universal nanowell plate featuring 28,000 partitions. The expected concentrations lay within the 95% confidence interval, affirming the accurate quantification achieved through digital PCR. Next, we measured the fraction of methylated alleles in various lung cancer and breast cancer cell lines, as well as in healthy human gDNA. The methylation of RASSF1A promoter in healthy human gDNA is ~0.7%, while a broad range of methylation levels was observed in cancer cell lines, ranging from ~0.7% to ~100.2%. Notably, the influence of GC bias was identified in this study. To overcome this critical challenge, we optimized the usage of several high GC enhancers. The results demonstrated that the concentration of 5-7.5% DMSO, 7.5% glycerol, and commercially available OneTaq or Q5 GC enhancers from New England Biolabs were effectively incorporated into the Roche digital PCR system, thereby enhancing the accuracy of quantification from 30% to 100%. Together, we demonstrated a remarkable approach for DNA methylation analysis using Roche digital PCR system in combination with MSREs and suitable high GC enhancers. This study suggests a promising rapid, accurate and cost-effective tool to advance research in the field. *Data on file at Roche Diagnostics, Wilmington, MA, USA Citation Format: Yu Zhao, Lindsey Cambria. Quantification of DNA methylation using methylation-sensitive restriction enzymes and digital PCR [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 7009.

High-throughput Hacking of the Methylation Patterns in Breast Cancer by in Vitro Transcription and Thymidine-Specific Cleavage Mass Array on MALDI-TOF Silico-Chip.

Methylation Profiles of 22 Candidate Genes in Breast Cancer Using High-Throughput MALDI-TOF Mass Array

Assaying DNA Methylation Based on High-Throughput Melting Curve Approaches

Methylation Pattern Analysis Using High‐throughput Microarray of Solid‐phase Hyperbranched Rolling Circle Amplification Products

Single copy-sensitive electrochemical assay for circulating methylated DNA in clinical samples with ultrahigh specificity based on a sequential discrimination-amplification strategy

High-throughput Method for Detecting DNA Methylation

Hypermethylation of Tumor Suppressor Genes Involved in Critical Regulatory Pathways for Developing A Blood-Based Test in Breast Cancer

Surface ligation-based resonance light scattering analysis of methylated genomic DNA on a microarray platform.

Highly Sensitive and Multiplexed Analysis of Cpg Methylation at Single-Base Resolution with Ligation-Based Exponential Amplification

The establishment of a new high-throughput method for evaluating the methylation status of lung cancer gene

Ultrasensitive amplification-free quantification of a methyl CpG-rich cancer biomarker by single-molecule kinetic fingerprinting

High-Throughput-Methyl-Reading (HTMR) Assay: a Solution Based on Nucleotide Methyl-Binding Proteins Enables Large-Scale Screening for DNA/RNA Methyltransferases and Demethylases

An improved method for genome wide DNA methylation profiling correlated to transcription and genomic instability in two breast cancer cell lines

Absolute quantification of DNA methylation using microfluidic chip-based digital PCR

Abstract 7009: Quantification of DNA methylation using methylation-sensitive restriction enzymes and digital PCR

High-Throughput Methylation Sequencing Of Targeted Genes In Breast Cancer Specimens Using Nanofluidic Pcr Prepared Libraries

Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer

IMPRESS: Improved methylation profiling using restriction enzymes and smMIP sequencing, combined with a new biomarker panel, creating a multi-cancer detection assay

The development and validation of a novel targeted methylation sequencing technology detecting 0.003 percent tumor signal in early-stage cancer plasma.

Development of methionine methylation profiling and relative quantification in human breast cancer cells based on metabolic stable isotope labeling.

Accurate Electrochemistry Analysis of Circulating Methylated DNA from Clinical Plasma Based on Paired-End Tagging and Amplifications